Astellas Venture Management
astellasventure.com Direct investor
Astellas Venture Management is the wholly-owned venture capital organization of Astellas Pharma, investing in early-stage biotechnology companies developing therapeutic programs and platform technologies. It focuses on preclinical stage companies that align with Astellas' R&D strategy and address unmet medical needs.
Astellas Venture Management is a corporate venture arm headquartered in South San Francisco, United States. It invests directly in companies, from seed to Series A, in biotechnology, therapeutics, platform technologies and drug discovery. 24 portfolio companies, as it reports.
“We will make an investment in privately owned early-stage biotechnology company focused on therapeutics programs and platform technologies for drug discovery and development.”
— Astellas Venture Management, own website
- Layer
- Direct investor
- Headquarters
- South San Francisco, United States
- Invests in
- US, UK, Japan
- Sectors
- biotechnology, therapeutics, platform technologies, drug discovery, drug development
- Portfolio
- 24 companies
Team, as Astellas Venture Management publishes it
- Satoshi Konagai Investment Lead
- Tadayoshi Hirata Investment Lead
- Shinichi Miyake Investment Lead
- Hiroyuki Usuda Investment Lead
- Amy Skarr President
- Matt Vogt Board of Managers
- Veronika Hughes-Bednar Board of Managers
Names and roles exactly as listed on astellasventure.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 36 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- Longwood Fund 5 shared companies: sidewinderbio.com, dembiopharma.com, solutherapeutics.com, bicycletherapeutics.com…
- Sofinnova 3 shared companies: catamaranbio.com, crescendobiologics.com, f2g.com
- Ahren Innovation Capital LLP 2 shared companies: mogrify.co.uk, bicycletherapeutics.com
- Lightstone Ventures 2 shared companies: tizonatx.com, trishulatx.com
- Andera Partners 1 shared company: crescendobiologics.com
- IP Group plc 1 shared company: crescendobiologics.com
- Quan Capital Management, LLC 1 shared company: crescendobiologics.com
- Advent Life Sciences LLP 1 shared company: f2g.com
- Aisling Capital Management LP 1 shared company: f2g.com
- AMR Action Fund 1 shared company: f2g.com
and 26 more — the graph.
Where this comes from
Every fact above was read from a page Astellas Venture Management publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.astellasventure.com/name, is_investor, layer, type, hq_country, hq_city, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, status
- https://www.astellasventure.com/home/portfolioinvests_in_geographies, portfolio_count
- https://www.astellasventure.com/home/teampeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 1203 · added 2026-08-28 · link last verified 2026-10-21 · confidence high
Similar investors
- DanaherCorporate venture · Washington, United States
- LG Technology VenturesCorporate venture · Seed – Growth · Silicon Valley, United States
- Regeneron VenturesCorporate venture · Greenwich, United States
- Acario InnovationCorporate venture · Silicon Valley, United States
- Accenture VenturesCorporate venture · United States
- Airbus VenturesCorporate venture · Menlo Park, United States